WCLC 2025 - Posters & ePosters-P3.12.35 Real-World Clinical Outcomes of Osimertinib in Patients With Recurrent EGFR Mutated Lung Adenocarcinoma: A Multicenter Study

P3.12.35 Real-World Clinical Outcomes of Osimertinib in Patients With Recurrent EGFR Mutated Lung Adenocarcinoma: A Multicenter Study

Asset Subtitle

Ichidai Tanaka

Meta Tag

Speaker Ichidai Tanaka

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy